Post by Sanofi

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended approval for our treatment for adults with uncontrolled chronic obstructive pulmonary disease (#COPD) with raised blood eosinophils. If approved, this medicine would be the first-ever targeted therapy for this disease and first new treatment approach in more than a decade. Read more about the news: https://lnkd.in/eQm69VPw Regeneron